Literature DB >> 16700206

[Penile prosthesis for the treatment of erectile dysfunction].

G Atienza Merino1.   

Abstract

The erectile dysfunction is a pathology that, with different degrees of intensity, affects nearly the 20% of the spanish adult men. The treatment is usually performed in stages, reserving the penile prosthesis for when other previous treatments have failed. The aim of this work is to evaluate, according to the state of present knowledge, the effectiveness and security of the penile prosthesis for the treatment of the erectile dysfunction. With this purpose 52 articles were selected, observing a 5 years prosthesis survival of 78-91% and a 3-8% of surgical complications. Mechanical failures and infection percentages were smaller in the semi-rigid prosthesis that in the inflatable ones, with high levels of postoperative satisfaction in patients as well as in their couples, even greater than in other treatments available at the present time. The penile prosthesis implantation must be reserved for the organic erectile dysfunction when previous treatments have failed, evaluating the risk-benefit relation and informing the patient of the results that are hoped to be obtained and of the possible complications that can arise. In view of the great concern of our society with the erectile function and the availability of effective drugs, an increase in the demand of penile prosthesis implantation is predictable in those patients highly motivated, but refractory to the less invasive treatments.

Entities:  

Mesh:

Year:  2006        PMID: 16700206     DOI: 10.1016/s0210-4806(06)73418-0

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  8 in total

1.  [A cylinder aneurysm of a penile prosthesis].

Authors:  J Pannek; P Bartel; K Göcking
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

2.  Long-term outcomes of AMS Spectra® penile prosthesis implantation and satisfaction rates.

Authors:  F Akdemir; E Okulu; Ö Kayıgil
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

3.  Comment on: Comparative analysis of inflatable penile prosthesis in patients with vasculogenic erectile dysfunction versus post-radical prostatectomy erectile dysfunction.

Authors:  Daniar Osmonov
Journal:  Int J Impot Res       Date:  2020-04-14       Impact factor: 2.896

4.  Penile prostheses.

Authors:  Carlo Bettocchi; Fabrizio Palumbo; Marco Spilotros; Silvano Palazzo; Gabriele A Saracino; Pasquale Martino; Michele Battaglia; Francesco P Selvaggi; Pasquale Ditonno
Journal:  Ther Adv Urol       Date:  2010-02

5.  Infection rate of penile prosthesis implants in men with spinal cord injury: a meta-analysis of available evidence.

Authors:  Daniele Tienforti; Maria Totaro; Luca Spagnolo; Francesca Di Giulio; Chiara Castellini; Giorgio Felzani; Marco Giorgio Baroni; Sandro Francavilla; Arcangelo Barbonetti
Journal:  Int J Impot Res       Date:  2022-10-18       Impact factor: 2.408

6.  Penile prosthesis implantation in Chinese patients with severe erectile dysfunction: 10-year experience.

Authors:  Wei-Dong Song; Yi-Ming Yuan; Wan-Shou Cui; Alex K Wu; Yi-Chen Zhu; Jing Liu; Lin Wang; Guang-Yi Bai; Jing Peng; Zhi-Chao Zhang; Bing Gao; Ying-Lu Guo; Tom F Lue; Zhong-Cheng Xin
Journal:  Asian J Androl       Date:  2013-07-22       Impact factor: 3.285

7.  Surgical outcomes and complications of Tube® (Promedon) malleable penile prostheses in diabetic versus non-diabetic patients with erectile dysfunction.

Authors:  Elnisr Rashed Mohamed; Ahmed Rashed Hammady; Mohamed Zaki Eldahshoury; Ahmed Mamdouh Elsharkawi; Ahmed Mahmoud Riad; Hazem Mohamed Elmogazy; Mohamed Mostafa Hussien; Wael Mohamed Gamal
Journal:  Arab J Urol       Date:  2016-08-25

8.  Outcome of penile prosthesis implantation: are malleable prostheses an appropriate treatment option in patients with erectile dysfunction caused by prior radical surgery?

Authors:  Cuneyd Sevinc; Orkunt Ozkaptan; Muhsin Balaban; Ugur Yucetas; Tahir Karadeniz
Journal:  Asian J Androl       Date:  2017 Jul-Aug       Impact factor: 3.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.